People

Des Jarlais
Don C. Des Jarlais, PhD
CDUHR - Associate Director, Infectious Disease Epidemiology and Theory Core
NYU College of Global Public Health - Professor
Education
PhD, Social Psychology, University of Michigan, Ann Arbor
BA, Behavioral Science, Rice University
Research Interests
Injecting drug use, Epidemiology, HIV, HCV, Research synthesis
BIO
For over 30 years Don Des Jarlais has been conducting HIV/AIDS research among persons who inject drugs (PWID). He is PI of the “Risk Factors” study (R01DA003574), which was instrumental in tracking the HIV/AIDS epidemic in New York City. This study has been funded by the National Institute on Drug Abuse since 1983 and is the longest continuously funded study on HIV/AIDS in persons who use drugs. He has conducted HIV/AIDS research nationally (Seattle, CDC CIDUS studies, national syringe exchange survey) and internationally (in over 20 different countries). He has served as a consultant on these issues to the World Health Organization, the National Institutes of Health and the U.S. Centers for Disease Control and Prevention.
Projects
Principal Investigator, Combined Prevention to Reduce Initiation Into Injecting Drug Use. Active
Principal Investigator, DRIVE (Drug Use and Blood-Borne Infections in Vietnam): Combined Prevention and Care to End the HIV Epidemic Among People Who Inject Drugs in Haiphong, Vietnam. Active
Principal Investigator, Evaluating ART for All HIV Seropositives: Can It Work with the Hardest Cases?. Active
Principal Investigator, Risk Factors for AIDS among Drug Users: Getting Close to Zero. Active
Principal Investigator, Barriers to Reason: Laws Impacting HIV Prevention Efforts among IDUs in the United States. Completed
Principal Investigator, Combined HIV Prevention for PWID and Future Collaborative Research in Vietnam. Completed
Principal Investigator, Expanded Syringe Access Program: NY Evaluation (ESAP). Completed
Principal Investigator, HIV Infection in Ethnic Minority IDUs: An International Systematic Review. Completed
Principal Investigator, HIV Transmission among Injecting and Non-Injecting Drug Users in Tallinn, Estonia. Completed
Principal Investigator, Multiple HIV Prevention Packages for IDUs in Estonia. Completed
Principal Investigator, National Study of Syringe Exchange Programs. Completed
Principal Investigator, WHO Survey Coordinating Center, Drug Injecting Study – Phase 2. Completed
Publications

Recent

Behrends CN, Nugent AV, Des Jarlais DC, Frimpong JA, Perlman DC, Schackman BR (2018).
Availability of HIV and HCV on-site testing and treatment at syringe service programs in the United States
Journal of Acquired Immune Deficiency Syndromes, 79 (2), e76-e78. doi: 10.1097/QAI.0000000000001792.

McKnight C, Des Jarlais DC (2018).
Being “hooked up” during a sharp increase in the availability of illicitly manufactured fentanyl: Adaptations of drug using practices among people who use drugs (PWUD) in New York City
International Journal of Drug Policy, 60, 82-88. doi: 10.1016/j.drugpo.2018.08.004.

Des Jarlais DC, Arasteh K, Feelemyer J, McKnight C, Barnes DM, Perlman DC, Uuskula A, Cooper HLF, Tross S (2018).
Hepatitis C virus prevalence and estimated incidence among new injectors during the opioid epidemic in New York City, 2000-2017: Protective effects of non-injecting drug use
Drug and Alcohol Dependence, 192, 74-79. doi: 10.1016/j.drugalcdep.2018.07.034.

Des Jarlais DC, Duong HT (2018).
Ending HIV epidemics among people who inject drugs in LMICs
Lancet, 392 (10149), 714-719. doi: 10.1016/S0140-6736(18)31721-5.

Barnes DM, Des Jarlais DC, Wolff M, Feelemyer J, Tross S (2018).
A qualitative study of persons who inject drugs but who have never helped others with first injections: How their views on helping contrast with the views of persons who have helped with first injections, and implications for interventions
Harm Reduction Journal, 15 (1), 43. doi: 10.1186/s12954-018-0250-x. PMCID: PMC6114536.

Selected Press